tiprankstipranks
Advertisement
Advertisement
Adaptive Biotechnologies Plans MRD and Immune Medicine Split
PremiumCompany AnnouncementsAdaptive Biotechnologies Plans MRD and Immune Medicine Split
19d ago
Adaptive to plans to separate minimal residual disease, immune medicine segments
Premium
The Fly
Adaptive to plans to separate minimal residual disease, immune medicine segments
19d ago
Adaptive Biotechnologies Shareholders Back Board, Pay and Auditor
Premium
Company Announcements
Adaptive Biotechnologies Shareholders Back Board, Pay and Auditor
25d ago
Adaptive Biotechnologies Leans on MRD in Earnings Call
PremiumCompany AnnouncementsAdaptive Biotechnologies Leans on MRD in Earnings Call
2M ago
Adaptive Biotechnologies Charts Profit Path After MRD Surge
Premium
Company Announcements
Adaptive Biotechnologies Charts Profit Path After MRD Surge
5M ago
3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts
5M ago
Adaptive Biotechnologies: Strong MRD Momentum, Enhanced 2026 Outlook, and Clear Path to Profitability Support Buy Rating
PremiumRatingsAdaptive Biotechnologies: Strong MRD Momentum, Enhanced 2026 Outlook, and Clear Path to Profitability Support Buy Rating
5M ago
Adaptive Biotechnologies reports Q4 EPS (9c), consensus (18c)
Premium
The Fly
Adaptive Biotechnologies reports Q4 EPS (9c), consensus (18c)
5M ago
Adaptive Biotechnologies sees FY26 operating expenses $350M-$360M
Premium
The Fly
Adaptive Biotechnologies sees FY26 operating expenses $350M-$360M
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100